Fidelity Covington Trust · net assets $3.29B · 337 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.8% · STIV: 0.1% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $56.8M | $34.5M | $51.3M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $0 | $15.2M | $38.7M |
| Net realized gain (non-derivative) | $344K | $-5.49M | $21.7M |
| Net unrealized appreciation (non-derivative) | $73.6M | $219M | $34.3M |
The three months of the reporting period, as filed; month 3 ends July 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly & Co EC | $439M | 13.35% |
| Johnson & Johnson EC | $294M | 8.93% |
| Abbvie Inc EC | $211M | 6.42% |
| Unitedhealth Group Inc EC | $179M | 5.44% |
| Merck & Co Inc EC | $153M | 4.66% |
| Thermo Fisher Scientific Inc EC | $102M | 3.09% |
| Amgen Inc EC | $98.8M | 3.00% |
| Abbott Laboratories EC | $87.6M | 2.66% |
| Gilead Sciences Inc EC | $76.9M | 2.34% |
| Pfizer Inc EC | $67.7M | 2.06% |
| Bristol-myers Squibb Co EC | $63.4M | 1.93% |
| Cvs Health Corp EC | $63.2M | 1.92% |
| Intuitive Surgical Inc EC | $59.7M | 1.82% |
| Danaher Corp EC | $59.1M | 1.80% |
| Vertex Pharmaceuticals Inc EC | $57.7M | 1.76% |
| Stryker Corp EC | $53.4M | 1.62% |
| Medtronic PLC EC | $52.2M | 1.59% |
| Mckesson Corp EC | $49.9M | 1.52% |
| Elevance Health Inc EC | $39.3M | 1.19% |
| Regeneron Pharmaceuticals Inc EC | $37.7M | 1.15% |
| Cigna Group/the EC | $35M | 1.06% |
| Boston Scientific Corp EC | $33M | 1.00% |
| Hca Healthcare Inc EC | $30M | 0.91% |
| Cencora Inc EC | $27.4M | 0.83% |
| Cardinal Health Inc EC | $25.7M | 0.78% |
| Edwards Lifesciences Corp EC | $23.6M | 0.72% |
| Becton Dickinson & Co EC | $22.5M | 0.68% |
| Idexx Laboratories Inc EC | $21.1M | 0.64% |
| Humana Inc EC | $20.8M | 0.63% |
| Iqvia Holdings Inc EC | $19M | 0.58% |
| Agilent Technologies Inc EC | $18.6M | 0.57% |
| Waters Corp EC | $17.7M | 0.54% |
| Natera Inc EC | $17.2M | 0.52% |
| Zoetis Inc EC | $15.5M | 0.47% |
| Dexcom Inc EC | $15.3M | 0.46% |
| Ge Healthcare Technologies Inc EC | $14.8M | 0.45% |
| Resmed Inc EC | $14.6M | 0.44% |
| Centene Corp EC | $14.6M | 0.44% |
| Illumina Inc EC | $14.6M | 0.44% |
| Revolution Medicines Inc EC | $14.4M | 0.44% |
| Veeva Systems Inc EC | $14.3M | 0.43% |
| Biogen Inc EC | $14.2M | 0.43% |
| Mettler-toledo International Inc EC | $13.7M | 0.42% |
| Alnylam Pharmaceuticals Inc EC | $13M | 0.39% |
| Quest Diagnostics Inc EC | $12.2M | 0.37% |
| Labcorp Holdings Inc EC | $12.1M | 0.37% |
| West Pharmaceutical Services Inc EC | $11.7M | 0.36% |
| Royalty Pharma PLC EC | $11.4M | 0.35% |
| Steris PLC EC | $10.6M | 0.32% |
| Tenet Healthcare Corp EC | $10.6M | 0.32% |
| Insmed Inc EC | $9.88M | 0.30% |
| Viatris Inc EC | $9.74M | 0.30% |
| United Therapeutics Corp EC | $9.72M | 0.30% |
| Incyte Corp EC | $9.63M | 0.29% |
| Guardant Health Inc EC | $9.36M | 0.28% |
| Moderna Inc EC | $8.76M | 0.27% |
| Zimmer Biomet Holdings Inc EC | $8.63M | 0.26% |
| Neurocrine Biosciences Inc EC | $7.55M | 0.23% |
| Roivant Sciences Ltd EC | $7.5M | 0.23% |
| Medline Inc EC | $6.89M | 0.21% |
Showing top 60 of 337 holdings.
Loading...
